Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04739462 · ClinicalTrials.gov registry record · NA

SMS Maama Project COVID-19

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
248
Enrollment target

NCT04739462: Completed NA study, sponsored by University of Minnesota.

NCT04739462 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04739462, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target

Study Summary

The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.

Primary Outcome

Outcome is reported as the percent of pregnant participants who recognize key danger signs during pregnancy, labor and childbirth, and postpartum period. Knowledge is measured pre-intervention (approximately 24-26 weeks gestation) and post-intervention (approximately 2 weeks following delivery). The timeframe is calculated to be 16-18 weeks.

Interventions

  • BEHAVIORAL mHealth Platform

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2021-09-28
Est. Completion 2021-10-21
Phase NA
University of Minnesota

966 total trials

What the finished NCT04739462 record still lists

NCT04739462 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which mHealth Platform is the first listed.

NCT04739462 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04739462 about?

NCT04739462 is a clinical study titled "SMS Maama Project COVID-19". The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.

What is the current status of trial NCT04739462?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2021-09-28. Estimated completion is 2021-10-21.

What interventions are being tested in trial NCT04739462?

The interventions under investigation include: mHealth Platform (BEHAVIORAL).

Who is sponsoring clinical trial NCT04739462?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04739462's enrollment target sits among peer trials

248 434th of 2000 higher than 1,565 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04577911 · 248 participants

    How is Social Connection Represented in the Brain?

  • NCT04777994 · 248 participants · Phase 1

    Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • NCT04792489 · 248 participants · Phase 2

    DALY II USA/ MB-CART2019.1 for DLBCL

  • NCT04830137 · 248 participants · Phase 1

    A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04739462, the US trial registry maintained by the National Library of Medicine. NCT04739462 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.